Understanding post-approval performance of medical devices is inherently challenging whether through randomized trials or real-world data (RWD). Device researchers are often limited to studying broad device classes or setting up agreements with individual providers or health systems to collect necessary data.
In this webinar, the expert speakers will have an in-depth discussion on advancing medical device performance and patient outcomes using complete electronic health records (EHR) data. They will share insights into their partnership to address gaps in real-world device performance data, foster innovation, promote health equity and inform clinical guidelines.
The understanding of post-approval medical device performance can be revolutionized by providing access to complete EHR data, including device-level data, clinical notes and medical images, for more than 100 million patients. These data can be standardized to a common model, linked across health systems and enriched with social determinants of health, mortality and claims data for a holistic view of patient journeys.
In this webinar, the speakers highlight published research using data on device utilization and safety for peripheral artery disease and pulmonary embolism as well as discuss how future research and research collaborations can be conducted using standardized data models.
Register for this webinar today to discover how complete EHR data are advancing medical device performance and improving patient outcomes.
Speakers
Dr. Ryan Ahern, Co-Founder and Chief Medical Officer, Truveta
Dr. Ryan Ahern is Co-founder and Chief Medical Officer of Truveta and has more than a decade of experience in healthcare data and clinical research. At Truveta, Ryan leads the Life Science Partner team, which focuses on developing new partnerships and ensuring those partners are successful in their research.
He is currently a Clinical Assistant Professor of Medicine at the University of Washington School of Medicine and practices at Harborview Medical Center, Seattle’s large county hospital. Prior to this, he trained in internal medicine at the Massachusetts General Hospital and has served as a Clinical Assistant Professor of Medicine at Weill Cornell Medical Center and New York Presbyterian; served as a Physician at Massachusetts General Hospital and was an Instructor at Harvard Medical School.
Message Presenter
Dr. Michael R. Jaff, Chief Medical Officer and Vice-President of Clinical Affairs, Technology and Innovation, Peripheral Interventions, Boston Scientific Corporation
Dr. Michael R. Jaff, DO, is the Chief Medical Officer and Vice President of Clinical Affairs, Technology and Innovation, Peripheral Interventions, Boston Scientific Corporation. A Professor of Medicine at Harvard Medical School, Dr. Jaff was the President of Newton-Wellesley Hospital from October 2016 to December 2019.
Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. He was the founder of VasCore, the Vascular Ultrasound Core Laboratory, which has participated in trial design and independent analysis of vascular laboratory images for over 200 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.
Dr. Jaff has published extensively in the field of Vascular Medicine with over 300 peer-reviewed publications and 10 textbooks and is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Intervention. He is also a registered physician in vascular interpretation (RPVI).
Message PresenterWho Should Attend?
This webinar will appeal to life sciences leaders focused on:
- Real-world evidence/Real-world data/HEOR
- Evidence generation
- Safety/Regulatory/Medical affairs
- Clinical development
- Market access
- Digital health
What You Will Learn
Attendees will learn about:
- How real-world data can be used to assess the safety of novel interventions to fill gaps in market understanding and inform clinical guidelines
- Findings from studies highlighting disparities in pulmonary embolism and peripheral artery disease treatment utilization and outcomes by race and sex
- How collaboration with health system researchers is driving market understanding, product validation and strategic business decisions
Xtalks Partner
Truveta
Truveta is a growing collective of 30 health systems with a shared mission of Saving Lives with Data. Truveta delivers the most complete, timely, and clean regulatory-grade EHR data for scientifically rigorous research. Truveta is trusted by more than 60 leading life science, government, academic, health system, and research organizations to accelerate adoption of therapies and advance patient care.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account